Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatocellular Carcinoma
100%
Personalized Therapy
100%
Molecular Diagnostics
100%
Malignancy
50%
Targeted Therapy
33%
Prognostic Biomarker
33%
Treatment Monitoring
33%
Hepatocellular Carcinoma Patient
33%
Epigenetic Modification
16%
Oncogenic Signaling
16%
Molecular Mechanism
16%
Cell-based
16%
Recent Advances
16%
Cancer Mortality
16%
Patient Outcomes
16%
Diagnosis Treatment
16%
Cancer Causes
16%
Poor Prognosis
16%
Excess Mortality
16%
Genetic Modification
16%
Individualized Treatment
16%
Hepatocellular Carcinoma Surveillance
16%
Complex Etiology
16%
Late Diagnosis
16%
Precision Medicine
16%
Next-generation Sequencing Technology
16%
Extracellular Vesicles
16%
Combination Strategy
16%
Clinical Prognosis
16%
Management Options
16%
Interdisciplinary Collaboration
16%
Prognosis Prediction
16%
Evolving Landscape
16%
Circulating Tumor DNA (ctDNA)
16%
Circulating Tumor Cells
16%
Effective Combination
16%
Monitoring Disease Progression
16%
Liquid Biopsy
16%
Prognosis Treatment
16%
Treatment Response Prediction
16%
Therapy Prediction
16%
Tumor-agnostic
16%
Immune Checkpoint Inhibitors
16%
Diagnostic Intervention
16%
High-throughput Sequencing Technology
16%
Precision Therapy
16%
Immunology and Microbiology
Mortality Rate
100%
Signal Transduction
100%
Next Generation Sequencing
100%
High Throughput Sequencing
100%
Circulating Tumor Cell
100%
Prognostic Biomarker
100%
Immune Checkpoint Inhibitor
100%
Biochemistry, Genetics and Molecular Biology
Targeted Therapy
100%
Genetics
50%
Carcinogenesis
50%
Signal Transduction
50%
Mortality Rate
50%
Next Generation Sequencing
50%
High Throughput Sequencing
50%
Circulating Tumor DNA
50%
Immune Checkpoint Inhibitor
50%
Molecular Mechanism
50%
Prognostic Biomarker
50%
Liquid Biopsy
50%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Personalized Medicine
100%
Molecular Diagnosis
100%
Cancer
33%
Targeted Therapy
22%
Molecular Diagnostics
22%
Malignant Neoplasm
11%
Patient Monitoring
11%
Disease Exacerbation
11%
Neoplasm
11%
Carcinogenesis
11%
Biological Marker
11%
Treatment Response
11%
Signal Transduction
11%
Cell Therapy
11%
Mortality Rate
11%
Cancer Diagnosis
11%
Next Generation Sequencing
11%
Immune Checkpoint Inhibitor
11%
Circulating Tumor DNA
11%
Circulating Tumor Cell
11%
Liquid Biopsy
11%
Etiology
11%
Genetics
11%